Identification of a Cell of Origin for Human Prostate Cancer
Top Cited Papers
- 30 July 2010
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 329 (5991), 568-571
- https://doi.org/10.1126/science.1189992
Abstract
Another Cell Culprit in Prostate Cancer: A recent controversial hypothesis about the cellular origins of human cancer, the so-called “cancer stem cell hypothesis,” has fueled interest in identifying the specific cell types that give rise to common epithelial cancers. A single, well-defined cell of origin could, in principle, lead to more effective targeted therapies. Based on histological evidence and/or studies of mouse tumors, luminal cells are believed to be the cell of origin in prostate cancer. Now, using functional assays of cells derived from benign human prostate tissue, Goldstein et al. (p. 568 ) find that a different cell type, basal cells, can give rise in mice to prostate tumors that closely resemble human prostate tumors. Thus, the cellular origin of prostate cancer may be more complex than anticipated.This publication has 31 references indexed in Scilit:
- Basal epithelial stem cells are efficient targets for prostate cancer initiationProceedings of the National Academy of Sciences of the United States of America, 2010
- Human prostate sphere‐forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivoThe Prostate, 2009
- A luminal epithelial stem cell that is a cell of origin for prostate cancerNature, 2009
- Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesisNature Genetics, 2009
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostateNature Genetics, 2009
- Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristicsProceedings of the National Academy of Sciences of the United States of America, 2008
- Efficient tumour formation by single human melanoma cellsNature, 2008
- The current state of preclinical prostate cancer animal modelsThe Prostate, 2008
- Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptorProceedings of the National Academy of Sciences of the United States of America, 2006
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003